Last checked at 
Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Ahead of its annual general meeting on Friday morning, says revenue for the six months to December 31 will be "significantly higher" than GBP1.1 million a year ago. Adds that it remains "hugely focused" on continuing to grow revenue and reduce its cash-burn throughout the year ending June 30.
Current stock price: 9.00 pence, up 2.9%
12-month change: more than doubled from 4.00p
By Sabrina Penty, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.